MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
批准号:
3402169
负责人:
WILLIAM L KLEIN
金额:
$12.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-23 至 1993-08-31
关键词:
affinity chromatography autoradiography biological signal transduction chemical binding chickens cow electron microscopy gel electrophoresis gene expression genetic library genetic transcription genetic translation glycosylation histochemistry /cytochemistry hybridomas immunochemistry ligands molecular weight monoclonal antibody muscarinic receptor neural conduction neural information processing neural plasticity neurogenesis posttranslational modifications protein sequence protein structure function receptor expression synapses
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A 5-year molecular-level strategy is proposed for attacking an
important problem in vertebrate neurodevelopment: "How do CNS
neurons create postsynaptic zones specialized for proper signal
transduction?" The elementary activity of the brain is signaling
between cells -- mechanisms underlying development, maintenance
and plasticity of signal transduction are at the foundation of
brain function.
Muscarinic acetylcholine receptors have been selected as prototypes
for studying CNS postsynaptic specialization. These receptors are
implicated in a host of physiological and behavioral processes,
including conscious arousal, learning and memory. Moreover,
because Alzheimer's disease is associated with the death of ACh-
containing cells, new studies of cholinoceptive postsynaptic cells
could have considerable relevance to the public health.
The proposed work pursues fundamental questions stimulated by three
significant discoveries: (1) The CNS (but not heart) expresses a
novel 86 kDa "embryonic" type MAChR, abundant during neurite
growth, that developmentally down-regulates and is supplanted by
a 72 kDa "adult type" molecules; (2) In vivo, neurons stringently
regulate the placement of receptors, with all molecules localized
to dendrites even before synapses have formed; (3) Developing
neurons are "plastic" with respect to receptor placement and
expression of 86K/72K molecular types. These new and important
observations were made in studies of the chicken CNS, a widely-used
model for vertebrate neurodevelopment. Three specific aims have
been selected as most critical for expanding these findings:
(1) To establish the origin and structure of the 86 kDa and 72 kDa
receptor molecules by characterizing chicken receptor genes and
their transcription in the developing CNS.
(2) To determine where the 86K and 72K molecules are localized
relative to synaptic junctions, assessing possible mechanisms
underlying placement and plasticity.
(3) To compare the function of 86K and 72K receptors, investigating
possible novel growth-associated roles during the period of neurite
arborization and synaptogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physiological role of naturally-occuring amyloid beta oligomers
-
批准号:9759747
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2018
-
负责人:WILLIAM L KLEIN
-
依托单位:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
-
批准号:9202960
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2016
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8842908
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8683797
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8548221
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8446087
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7615522
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7184209
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7470605
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
-
批准号:6678227
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7805554
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6931646
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7467169
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6795925
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7595791
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6233462
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6615732
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6532552
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2703069
-
项目类别:
-
资助金额:$19.22万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2273680
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
海外基金